SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products, today announced that John Chiminski, Chairman
& Chief Executive Officer, will present at the 37th
Annual J.P. Morgan Health Care Conference at 10:30 a.m. PT on Monday,
January 7, 2019 in San Francisco, CA.
A live webcast of the presentations will be accessible through the
Company’s website at http://investor.catalent.com
and will be available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and consumer
health products. With over 80 years serving the industry, Catalent has
proven expertise in bringing more customer products to market faster,
enhancing product performance and ensuring reliable clinical and
commercial product supply. Catalent employs over 11,000 people,
including over 1,800 scientists, at more than 30 facilities across 5
continents and in fiscal 2018 generated approximately $2.5 billion in
annual revenue. Catalent is headquartered in Somerset, N.J. For more
information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
Investor Contact:
Thomas Castellano
Catalent, Inc.
(732) 537-6325
investors@catalent.com